Today a major milestone was reached in the evolution of women’s health technology. Emm now has UKCA marking and MHRA registration making it the world’s first regulatory cleared smart menstrual cup.

Closing the Data Gap in Women’s Health

This marks a turning point in how reproductive health is understood, tracked, and discussed. Over the past decade, consumer health technology has transformed how we understand our bodies. Devices now continuously monitor sleep quality, heart rate, stress levels, recovery patterns, and even glucose fluctuations. Yet, reproductive health has remained largely untouched by this wave of innovation.

Until now, menstrual tracking has relied heavily on memory and manual input, approximate calendar predictions based on averages, and subjective symptom reporting. This has created a significant gap in reliable, objective data, often leading to delayed diagnoses and overlooked health concerns. The Emm Cup is designed to change that.

From Guesswork to Ground Truth

The Emm Cup introduces a completely new approach: passive, biometric tracking of menstrual health. It doesn’t ask you to log, remember, or estimate. It measures. Silently. Passively. Precisely. For the first time, users can access their exact menstrual flow volume and daily flow rates, as well as longitudinal cycle patterns. No manual tracking. No subjective inputs. No averages, estimates or approximations. Just data you can trust.

When docked in its portable charging case, the cup syncs securely to a private, encrypted mobile app, transforming raw biological signals into clear, actionable insights. This isn’t period tracking, this is menstrual biometrics.

A First-of-Its-Kind Biowearable

The Emm Cup isn’t just another wearable. It’s a category-defining device. What sets the Emm Cup apart is not just its technology, but its design and placement. It is:

- A clinically validated, passive biowearable

- Made from medical-grade, hypoallergenic silicone

- Positioned at a unique biological interface no other wearable occupies

That last point matters because where other wearables infer, Emm directly measures. 

This combination allows the device to capture insights that have historically been inaccessible. Over time, users can build a personalized baseline of their cycle, enabling them to know their own normal, spot changes early, understand patterns and irregularities and share objective data with healthcare providers.

A Step Toward Better Diagnoses and Care

For many individuals, reproductive health symptoms are too often dismissed or misunderstood. Without measurable data, conversations with healthcare professionals can rely heavily on subjective descriptions. This is where Emm’s technology can have its greatest impact.

Emm Founder and CEO Jenny Button explains, “We can’t diagnose what we can’t define, but it shouldn’t take scalpels for our pain to be taken seriously. Today no one can characterise female-specific disease because we are missing the clinical baseline data for women. Menstrual baseline data is the missing piece. We believe our technology can act as a catalyst to unlock some of the world's least understood reproductive health challenges, turning subjective symptoms into objective, actionable data.”

By providing concrete metrics, the Emm Cup empowers users to advocate for their health with greater confidence and clarity. In other words: no more guessing, no more ignoring our bodies, no more “it’s probably normal.”

What UKCA Marking Means

The UKCA marking is a significant achievement. It confirms that the Emm Cup meets strict regulatory standards for safety, quality, and performance in the United Kingdom.

More importantly, it signals that the technology has passed rigorous validation, is ready for real-world use, and a new category of reproductive health devices is here. 

As Jenny Button says, “UKCA marking validates our technology requirements and opens the door for millions of people to truly know their health today and screen for their health tomorrow.”

What Comes Next

This milestone is just the beginning. Emm is now focusing on expanding its regulatory footprint globally, which includes pursuing FDA clearance in the United States, achieving ISO 13485 certification and scaling access to international markets.

Emm is a health intelligence company and pioneer in biowearable innovation, dedicated to closing the gender health data gap. This mission is ambitious, and urgent. 

The Emm Cup represents more than a new product, it signals a broader shift in women’s health. For the first time, menstrual health can be tracked with the same level of accuracy and automation as other key health metrics. This shift has the potential to improve early detection of reproductive health issues, enhance medical conversations and normalize a data-driven understanding of menstrual health for every body.

The future is measured. And it just got regulatory clearance.

To learn more about the Emm Cup or join the community, visit emm.co.